Deutsche Bank
IMVT icon

Deutsche Bank’s Immunovant IMVT Stock Holding History

Deutsche Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Buy
98,595
+19,595
+25% +$597K ﹤0.01% 1520
2026
Q1 		$1.96M Buy
79,000
+16,542
+26% +$428K ﹤0.01% 1786
2025
Q4 		$1.59M Buy
62,458
+7,673
+14% +$171K ﹤0.01% 1928
2025
Q3 		$883K Buy
54,785
+6,014
+12% +$97.4K ﹤0.01% 2246
2025
Q2 		$780K Sell
48,771
-362,738
-88% -$5.49M ﹤0.01% 2234
2025
Q1 		$7.03M Buy
411,509
+245,037
+147% +$5.13M ﹤0.01% 1122
2024
Q4 		$4.12M Buy
166,472
+16,903
+11% +$479K ﹤0.01% 1429
2024
Q3 		$4.26M Buy
149,569
+6,595
+5% +$195K ﹤0.01% 1345
2024
Q2 		$3.77M Sell
142,974
-2,451
-2% -$69.7K ﹤0.01% 1346
2024
Q1 		$4.7M Buy
145,425
+1,032
+0.7% +$37.6K ﹤0.01% 1291
2023
Q4 		$6.08M Buy
144,393
+109,400
+313% +$4.03M ﹤0.01% 1169
2023
Q3 		$1.34M Sell
34,993
-107,689
-75% -$2.43M ﹤0.01% 1560
2023
Q2 		$2.71M Buy
142,682
+102,461
+255% +$1.91M ﹤0.01% 1484
2023
Q1 		$624K Buy
40,221
+8,253
+26% +$143K ﹤0.01% 2369
2022
Q4 		$567K Buy
31,968
+5,381
+20% +$67.8K ﹤0.01% 2377
2022
Q3 		$148K Buy
26,587
+7,257
+38% +$35.5K ﹤0.01% 3127
2022
Q2 		$75K Sell
19,330
-4,278
-18% -$18.5K ﹤0.01% 3634
2022
Q1 		$130K Sell
23,608
-123,029
-84% -$766K ﹤0.01% 3478
2021
Q4 		$1.25M Buy
146,637
+1,548
+1% +$12.8K ﹤0.01% 2301
2021
Q3 		$1.26M Sell
145,089
-39,368
-21% -$355K ﹤0.01% 2464
2021
Q2 		$1.95M Buy
184,457
+24,511
+15% +$342K ﹤0.01% 2250
2021
Q1 		$2.57M Buy
159,946
+128,765
+413% +$3.4M ﹤0.01% 1983
2020
Q4 		$1.44M Buy
31,181
+10,105
+48% +$467K ﹤0.01% 2175
2020
Q3 		$742K Sell
21,076
-97,021
-82% -$2.92M ﹤0.01% 2386
2020
Q2 		$2.88M Buy
+118,097
New +$2.53M ﹤0.01% 1584

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank's IMVT Position: Q2 2026 in Review

Deutsche Bank increased its Immunovant (IMVT) stake by 25% in Q2 2026, buying an estimated $597K and bringing the position to 98,595 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

Deutsche Bank first reported a position in IMVT in Q2 2020 and has held it in 25 quarters since. The position peaked at $7.03M in Q1 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Deutsche Bank held 98,595 shares of Immunovant worth $3.8M as of Q2 2026.
  • Deutsche Bank bought 19,595 Immunovant shares in Q2 2026, an estimated $597K.
  • Immunovant made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1520 holding.
  • Deutsche Bank first reported a position in Immunovant in Q2 2020 and has held it in 25 quarters since.
  • Deutsche Bank's Immunovant position peaked at $7.03M in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.